𝔖 Bobbio Scriptorium
✦   LIBER   ✦

A meta-analysis of clinical trials of paclitaxel- and sirolimus-eluting stents in patients with obstructive coronary artery disease

✍ Scribed by N. Shafiq; S. Malhotra; P. Pandhi; A. Grover; A. Uboweja


Book ID
108640317
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
113 KB
Volume
59
Category
Article
ISSN
0306-5251

No coin nor oath required. For personal study only.


📜 SIMILAR VOLUMES


Five-year clinical outcomes of sirolimus
✍ K. Anette Birkmeier; Adnan Kastrati; Robert A. Byrne; Heidrun Holle; Stefanie Sc 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 336 KB 👁 2 views

## Abstract Objectives and Background: First generation drug‐eluting stents have shown differential efficacy in high‐risk patient subsets at one year. It is unclear whether these differences endure over the medium‐ to long‐term. We compared the five‐year clinical efficacy and safety of sirolimus‐el

Impact of three or more sirolimus-elutin
✍ William W. Chu; Pramod K. Kuchulakanti; Rebecca Torguson; Betty Wang; Leonardo C 📂 Article 📅 2006 🏛 John Wiley and Sons 🌐 English ⚖ 75 KB 👁 2 views

## Abstract ## Objectives: The purpose of this study was to examine the clinical outcomes of patients who underwent stenting with ≥3 sirolimus‐eluting stents (SES) when compared with those treated with ≥3 paclitaxel‐eluting stents (PES). ## Background: Drug‐eluting stent (DES) implantation for s

Improved Late Clinical Safety With Zotar